Source: International Congress 2019 – Novel findings from asthma clinical trials
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Eger (Amsterdam, Netherlands), M. Amelink (Amsterdam, Netherlands), P. Hekking (Amsterdam, Netherlands), E. Bel (Amsterdam, Netherlands). Late Breaking Abstract - Overuse of oral corticosteroids in asthma – modifiable factors and potential role of biologics. 5334

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - The burden of intermittent oral corticosteroid use in asthma Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science Year: 2021 What is the role of oral corticosteroids in the era of biologics in asthma? Source: International Congress 2019 – State of the art session: Airway disease Year: 2019 Late Breaking Abstract - Short-term and maintenance oral corticosteroid use for German patients with asthma Source: International Congress 2019 – Powerful cohort studies with/without lung function Year: 2019 Late Breaking Abstract - Oral corticosteroid (OCS) risk predictor for osteoporosis Source: Virtual Congress 2021 – Lung disease burden and management Year: 2021 Late Breaking Abstract: Fluticasone/salmeterol combination confers significant benefits in smoking asthmatics Source: Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies Year: 2010 Late Breaking Abstract - Impact of maintenance and reliever therapy (MART)-focused asthma guideline on SABA prescriptions Source: Virtual Congress 2021 – Highlights for primary care in 2021 Year: 2021 Late Breaking Abstract - Exacerbation of asthma in childhood: seasonal pattern and risk factors. Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities Year: 2017 Late Breaking Abstract - Overprescription of short-acting beta2-agonists in asthma management? Pharmacy reports from 91,673 patients in Poland Source: International Congress 2019 – New towards old therapies in airway diseases Year: 2019 High inhaled corticosteroids adherence in childhood asthma: the role of medication beliefs Source: Eur Respir J 2012; 40: 1072-1074 Year: 2012 Late Breaking Abstract - Cardiovascular adverse events of drugs targeting IL-5 in severe asthma: a pharmacovigilance study Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020 Known and emerging risk factors for asthma development: is prevention possible? Source: International Congress 2015 – Asthma: emerging risk factors and current management of the patient Year: 2015 Late Breaking Abstract - Identifying and addressing patient beliefs driving SABA use and over-reliance Source: International Congress 2019 – Novel findings from asthma clinical trials Year: 2019 Late Breaking Abstract - Shared genetic origins of obesity and poor ICS response in children with asthma Source: Virtual Congress 2021 – Lung disease burden and management Year: 2021 Late Breaking Abstract - Difference in clinical outcomes between smoking and non-smoking asthma patients who initiated an ICS or ICS/LABA treatment Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019 The mechanisms of antiinflammatory effect of mucolytic therapy Source: International Congress 2014 – Predictors Year: 2014 Use of NSAIDS compared to paracetamol as potential risk factors for asthma Source: Annual Congress 2010 - Paediatric respiratory epidemiology: early origins of childhood asthma Year: 2010 Effect of maintenance oral corticosteroids on risk factors for frequent exacerbations in a severe adult asthma population Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes Year: 2020 Metrics of salbutamol use as predictors of future adverse outcomes in asthma Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013 Is there a problem with oral corticosteroid use in asthma? Source: Virtual Congress 2020 – Airway diseases Year: 2020